Mark Schoenberg
Chief Medical Officer · 6 filings · Latest: Jul 9, 2026
UroGen Pharma Ltd.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
URGN | Mark Schoenberg | Chief Medical Officer | Jul 9, 2026 | Sale | $40.00 | 10,000 | $400.0K | 119,763 | |
URGN | Schoenberg Mark | — | Jul 9, 2026 | Proposed Sale | $40.00 | 10,000 | $400.0K | — | |
URGN | Mark Schoenberg | Chief Medical Officer | Jun 22, 2026 | Sale | $35.01 | 10,000 | $350.1K | 129,763 | |
URGN | Schoenberg Mark | — | Jun 22, 2026 | Proposed Sale | $35.01 | 10,000 | $350.1K | — | |
URGN | Mark Schoenberg | Chief Medical Officer | Jun 8, 2026 | Sale | $27.30 | 5,222 | $142.6K | 139,763 | |
URGN | Mark Schoenberg | Chief Medical Officer | Jun 8, 2026 | Option Exercise | — | 10,000 | — | 144,985 | |
URGN | Schoenberg Mark | — | Jun 8, 2026 | Proposed Sale | $26.85 | 5,222 | $140.2K | — | |
URGN | Mark Schoenberg | Chief Medical Officer | May 8, 2026 | Sale | $30.00 | 10,000 | $300.0K | 134,985 | |
URGN | Schoenberg Mark | — | May 8, 2026 | Proposed Sale | $30.00 | 10,000 | $300.0K | — | |
URGN | Mark Schoenberg | Chief Medical Officer | Feb 3, 2026 | Sale | $19.69 | 7,373 | $145.2K | 144,985 | |
URGN | Mark Schoenberg | Chief Medical Officer | Jan 31, 2026 | Option Exercise | — | 13,333 | — | 142,359 | |
URGN | Schoenberg Mark | — | Feb 2, 2026 | Proposed Sale | $19.61 | 13,333 | $261.5K | — | |
URGN | Schoenberg Mark | — | Nov 19, 2025 | Proposed Sale | $25.00 | 10,000 | $250.0K | — | |
URGN | Schoenberg Mark | — | Sep 8, 2025 | Proposed Sale | $18.88 | 871 | $16.4K | — | |
URGN | Schoenberg Mark | — | Jul 28, 2025 | Proposed Sale | $18.95 | 5,149 | $97.6K | — | |
URGN | Schoenberg Mark | — | Jun 9, 2025 | Proposed Sale | $7.37 | 5,162 | $38.0K | — | |
URGN | Schoenberg Mark | — | Sep 9, 2024 | Proposed Sale | $13.23 | 859 | $11.4K | — |